Related references
Note: Only part of the references are listed.Updates on immunologic correlates of vaccine-induced protection
Stanley A. Plotkin
VACCINE (2020)
Infant Hospitalizations and Fatalities Averted by the Maternal Pertussis Vaccination Program in England, 2012-2017: Post-implementation Economic Evaluation
Frank Sandmann et al.
CLINICAL INFECTIOUS DISEASES (2020)
The complex challenges of HIV vaccine development require renewed and expanded global commitment
Linda-Gail Bekker et al.
LANCET (2020)
Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies
Syed Faraz Ahmed et al.
VIRUSES-BASEL (2020)
Clinical Development of New TB Vaccines: Recent Advances and Next Steps
Mark Hatherill et al.
FRONTIERS IN MICROBIOLOGY (2020)
SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness
Kizzmekia S. Corbett et al.
NATURE (2020)
Next-generation vaccine platforms for COVID-19
Debby van Riel et al.
NATURE MATERIALS (2020)
Respiratory Syncytial Virus Vaccination during Pregnancy and Effects in Infants
S. A. Madhi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Why the elderly appear to be more severely affected byCOVID-19: The potential role of immunosenescence andCMV
Seilesh Kadambari et al.
REVIEWS IN MEDICAL VIROLOGY (2020)
Mapping functional humoral correlates of protection against malaria challenge following RTS,S/AS01 vaccination
Todd J. Suscovich et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
Fractional dose of intradermal compared to intramuscular and subcutaneous vaccination - A systematic review and meta-analysis
Jenny L. Schnyder et al.
TRAVEL MEDICINE AND INFECTIOUS DISEASE (2020)
Immunological considerations for COVID-19 vaccine strategies
Mangalakumari Jeyanathan et al.
NATURE REVIEWS IMMUNOLOGY (2020)
WHO consultation on group B Streptococcus vaccine development: Report from a meeting held on 27-28 April 2016
Miwako Kobayashi et al.
VACCINE (2019)
Principal Controversies in Vaccine Safety in the United States
Frank DeStefano et al.
CLINICAL INFECTIOUS DISEASES (2019)
New Vaccine Design and Delivery Technologies
Masaru Kanekiyo et al.
JOURNAL OF INFECTIOUS DISEASES (2019)
Pandemrix-induced narcolepsy is associated with genes related to immunity and neuronal survival
Par Hallberg et al.
EBIOMEDICINE (2019)
The MMR Vaccine and Autism
Frank DeStefano et al.
ANNUAL REVIEW OF VIROLOGY, VOL 6, 2019 (2019)
Novel approaches for the design, delivery and administration of vaccine technologies
J. Wallis et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2019)
A proof of concept for structure-based vaccine design targeting RSV in humans
Michelle C. Crank et al.
SCIENCE (2019)
Potential use of microarray patches for vaccine delivery in low- and middle- income countries
Nicolas Peyraud et al.
VACCINE (2019)
Immunosenescence and human vaccine immune responses
Stephen N. Crooke et al.
IMMUNITY & AGEING (2019)
Challenges in evaluating post-licensure vaccine safety: observations from the Centers for Disease Control and Prevention
Pedro L. Moro et al.
EXPERT REVIEW OF VACCINES (2019)
Ebola vaccine trials: progress in vaccine safety and immunogenicity
Keesha M. Matz et al.
EXPERT REVIEW OF VACCINES (2019)
Measles virus infection diminishes preexisting antibodies that offer protection from other pathogens
Michael J. Mina et al.
SCIENCE (2019)
Global Routine Vaccination Coverage, 2018
Megan Peck et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2019)
Final Analysis of a Trial of M72/AS01E Vaccine to Prevent Tuberculosis
D. R. Tait et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Advances in mRNA Vaccines for Infectious Diseases
Cuiling Zhang et al.
FRONTIERS IN IMMUNOLOGY (2019)
Conserved epitope on influenza-virus hemagglutinin head defined by a vaccine-induced antibody
Donald D. Raymond et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Incidence rate of breakthrough varicella observed in healthy children after 1 or 2 doses of varicella vaccine: Results from a meta-analysis
Sui Zhu et al.
AMERICAN JOURNAL OF INFECTION CONTROL (2018)
Age and immunity: What is immunosenescence?
Graham Pawelec
EXPERIMENTAL GERONTOLOGY (2018)
Association Between Estimated Cumulative Vaccine Antigen Exposure Through the First 23 Months of Life and Non-Vaccine-Targeted Infections From 24 Through 47 Months of Age
Jason M. Glanz et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
mRNA vaccines - a new era in vaccinology
Norbert Pardi et al.
NATURE REVIEWS DRUG DISCOVERY (2018)
Tetanus vaccines: WHO position paper, February 2017-Recommendations
VACCINE (2018)
Diphtheria vaccine: WHO position paper, August 2017-Recommendations
VACCINE (2018)
The geography of smallpox in England before vaccination: A conundrum resolved
Romola Jane Davenport et al.
SOCIAL SCIENCE & MEDICINE (2018)
New Vaccine Technologies to Combat Outbreak Situations
Susanne Rauch et al.
FRONTIERS IN IMMUNOLOGY (2018)
The state of vaccine confidence
Heidi J. Larson
LANCET (2018)
Original antigenic sin: A comprehensive review
Anup Vatti et al.
JOURNAL OF AUTOIMMUNITY (2017)
The safety, immunogenicity, and acceptability of inactivated influenza vaccine delivered by microneedle patch (TIV-MNP 2015): a randomised, partly blinded, placebo-controlled, phase 1 trial
Nadine G. Rouphael et al.
LANCET (2017)
Efficacy and immunogenicity of a Vi-tetanus toxoid conjugate vaccine in the prevention of typhoid fever using a controlled human infection model of Salmonella Typhi: a randomised controlled, phase 2b trial
Celina Jin et al.
LANCET (2017)
Prospects for preventing infant invasive GBS disease through maternal vaccination
Shabir A. Madhi et al.
VACCINE (2017)
Effectiveness of MF59-adjuvanted seasonal influenza vaccine in the elderly: A systematic review and meta-analysis
Alexander Domnich et al.
VACCINE (2017)
Prevalence and decay of maternal pneumococcal and meningococcal antibodies: A meta-analysis of type-specific decay rates
Merryn Voysey et al.
VACCINE (2017)
What Is Wrong with Pertussis Vaccine Immunity? The Problem of Waning Effectiveness of Pertussis Vaccines
Nicolas Burdin et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2017)
Immune persistence after pertussis vaccination
Zhiyun Chen et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2017)
The Influence of Maternally Derived Antibody and Infant Age at Vaccination on Infant Vaccine Responses An Individual Participant Meta-analysis
Merryn Voysey et al.
JAMA PEDIATRICS (2017)
AS03-and MF59-Adjuvanted influenza vaccines in Children
Amanda L. Wilkins et al.
FRONTIERS IN IMMUNOLOGY (2017)
Non-specific effects of vaccines: plausible and potentially important, but implications uncertain
Andrew J. Pollard et al.
ARCHIVES OF DISEASE IN CHILDHOOD (2017)
Developing an expanded vector control toolbox for malaria elimination
Gerry F. Killeen et al.
BMJ GLOBAL HEALTH (2017)
Immunisation of the immunocompromised child
Marta Valente Pinto et al.
JOURNAL OF INFECTION (2016)
Association of BCG, DTP, and measles containing vaccines with childhood mortality: systematic review
Julian P. T. Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
Association of BCG, DTP, and measles containing vaccines with childhood mortality: systematic review
Julian P. T. Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
Population-level impact, herd immunity, and elimination after human papillomavirus vaccination: a systematic review and meta-analysis of predictions from transmission-dynamic models
Marc Brisson et al.
LANCET PUBLIC HEALTH (2016)
Design, recruitment, and microbiological considerations in human challenge studies
Thomas C. Darton et al.
LANCET INFECTIOUS DISEASES (2015)
Efficacy of an Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults
Himal Lal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Long-term measles-induced immunomodulation increases overall childhood infectious disease mortality
Michael J. Mina et al.
SCIENCE (2015)
Vaccines and vaccination against yellow fever: WHO Position Paper, June 2013-Recommendations
VACCINE (2015)
RTS,S: Toward a first landmark on the Malaria Vaccine Technology Roadmap
David C. Kaslow et al.
VACCINE (2015)
Immunogenicity of reduced dose priming schedules of serogroup C meningococcal conjugate vaccine followed by booster at 12 months in infants: open label randomised controlled trial
David Pace et al.
BMJ-BRITISH MEDICAL JOURNAL (2015)
Immunogenicity of reduced dose priming schedules of serogroup C meningococcal conjugate vaccine followed by booster at 12 months in infants: open label randomised controlled trial
David Pace et al.
BMJ-BRITISH MEDICAL JOURNAL (2015)
Varicella zoster virus infection
Anne A. Gershon et al.
NATURE REVIEWS DISEASE PRIMERS (2015)
2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host
Lorry G. Rubin et al.
CLINICAL INFECTIOUS DISEASES (2014)
Assessment of herd immunity and cross-protection after a human papillomavirus vaccination programme in Australia: a repeat cross-sectional study
Sepehr N. Tabrizi et al.
LANCET INFECTIOUS DISEASES (2014)
Serotype-specific effectiveness and correlates of protection for the 13-valent pneumococcal conjugate vaccine: a postlicensure indirect cohort study
Nick J. Andrews et al.
LANCET INFECTIOUS DISEASES (2014)
Pregnancy and Infection
Athena P. Kourtis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Influenza Vaccination of Pregnant Women and Protection of Their Infants
Shabir A. Madhi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Efficacy of High-Dose versus Standard-Dose Influenza Vaccine in Older Adults
Carlos A. DiazGranados et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Low 2012-13 Influenza Vaccine Effectiveness Associated with Mutation in the Egg-Adapted H3N2 Vaccine Strain Not Antigenic Drift in Circulating Viruses
Danuta M. Skowronski et al.
PLOS ONE (2014)
Immune Activation with HIV Vaccines
Anthony S. Fauci et al.
SCIENCE (2014)
Risk groups for yellow fever vaccine-associated viscerotropic disease (YEL-AVD)
Stephen J. Seligman
VACCINE (2014)
Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial
Michele D. Tameris et al.
LANCET (2013)
Pharmacokinetic modeling as an approach to assessing the safety of residual formaldehyde in infant vaccines
Robert J. Mitkus et al.
VACCINE (2013)
Effectiveness of meningococcal serogroup C vaccine programmes
Ray Borrow et al.
VACCINE (2013)
Risk of narcolepsy in children and young people receiving AS03 adjuvanted pandemic A/H1N1 2009 influenza vaccine: retrospective analysis
Elizabeth Miller et al.
BMJ-BRITISH MEDICAL JOURNAL (2013)
Passive immunization for the public health control of communicable diseases Current status in four high-income countries and where to next
Megan K. Young et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2013)
Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis
Michael T. Osterholm et al.
LANCET INFECTIOUS DISEASES (2012)
A Phase 3 Trial of RTS,S/AS01 Malaria Vaccine in African Infants
Sara Mian-McCarthy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
AS03 Adjuvanted AH1N1 Vaccine Associated with an Abrupt Increase in the Incidence of Childhood Narcolepsy in Finland
Hanna Nohynek et al.
PLOS ONE (2012)
The vaccination coverage required to establish herd immunity against influenza viruses
Pedro Plans-Rubio
PREVENTIVE MEDICINE (2012)
Viral vectors as vaccine platforms: deployment in sight
Christine S. Rollier et al.
CURRENT OPINION IN IMMUNOLOGY (2011)
Vaccines for the twenty-first century society
Rino Rappuoli et al.
NATURE REVIEWS IMMUNOLOGY (2011)
Meningococcal vaccines and herd immunity: lessons learned from serogroup C conjugate vaccination programs
Caroline L. Trotter et al.
EXPERT REVIEW OF VACCINES (2009)
Original Antigenic Sin Responses to Influenza Viruses
Jin Hyang Kim et al.
JOURNAL OF IMMUNOLOGY (2009)
Randomized, Double-Blind Controlled Phase 3 Trial Comparing the Immunogenicity of High-Dose and Standard-Dose Influenza Vaccine in Adults 65 Years of Age and Older
Ann R. Falsey et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand
Supachai Rerks-Ngarm et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
BCG vaccination reduces risk of infection with Mycobacterium tuberculosis as detected by gamma interferon release assay
Michael Eisenhut et al.
VACCINE (2009)
No evidence of an increase of bacterial and viral infections following Measles, Mumps and Rubella vaccine
Julia Stowe et al.
VACCINE (2009)
Towards an understanding of the adjuvant action of aluminium
Philippa Marrack et al.
NATURE REVIEWS IMMUNOLOGY (2009)
Maintaining protection against invasive bacteria with protein-polysaccharide conjugate vaccines
Andrew J. Pollard et al.
NATURE REVIEWS IMMUNOLOGY (2009)
APRIL is critical for plasmablast survival in the bone marrow and poorly expressed by early-life bone marrow stromal cells
Elodie Belnoue et al.
BLOOD (2008)
Ageing and life-long maintenance of T-cell subsets in the face of latent persistent infections
Janko Nikolich-Zugich
NATURE REVIEWS IMMUNOLOGY (2008)
Immunization of early adolescent females with human papillomavirus type 16 and 18 L1 virus-like pailicle vaccine containing AS04 adjuvant
Court Pedersen et al.
JOURNAL OF ADOLESCENT HEALTH (2007)
Effect of BCG vaccination on childhood tuberculous meningitis and miliarytuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness
BB Trunz et al.
LANCET (2006)
Vaccine components and constituents: responding to consumer concerns
BE Eldred et al.
MEDICAL JOURNAL OF AUSTRALIA (2006)
Immunological memory - The role of B cells in long-term protection against invasive bacterial pathogens
DF Kelly et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
CD4+ T cells mediate antibody-independent acquired immunity to pneumococcal colonization
R Malley et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction
CL Trotter et al.
LANCET (2004)
Risk of anaphylaxis after vaccination of children and adolescents
K Bohlke et al.
PEDIATRICS (2003)
Estimating Haemophilus influenzae type b vaccine effectiveness in England and Wales by use of the screening method
ME Ramsay et al.
JOURNAL OF INFECTIOUS DISEASES (2003)
Immunologic memory in Haemophilus influenzae type b conjugate vaccine failure
J McVernon et al.
ARCHIVES OF DISEASE IN CHILDHOOD (2003)
Addressing parents' concerns: Do multiple vaccines overwhelm or weaken the infant's immune system?
PA Offit et al.
PEDIATRICS (2002)
Do parents understand immunizations? A national telephone survey
BG Gellin et al.
PEDIATRICS (2000)
Factors determining prevalence of maternal antibody to measles virus through infancy:: A review
VM Cáceres et al.
CLINICAL INFECTIOUS DISEASES (2000)
General non-specific morbidity is reduced after vaccination within the third month of life - the Greifswald study
S Otto et al.
JOURNAL OF INFECTION (2000)
Share Paper
